Array Technologies, Inc. Reports Financial Results for the First Quarter 2022 – Delivers strong top-line growth, a robust backlog and continued margin progression in the legacy Array business
Go back to Array Technologies, Inc. Reports Financial Results for the First Quarter 2022 – Delivers strong top-line growth, a robust backlog and continued margin progression in the legacy Array business| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 4.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.07 | 52 Week High | $7.27 | |||
| Open | $4.07 | 52 Week Low | $2.39 | |||
| Day High | $4.07 | P/E | N/A | |||
| Day Low | $4.07 | EPS | $-0.61 | |||
| Volume | 8,790 | |||||
